219 related articles for article (PubMed ID: 32457102)
21. Upregulation of interleukin-33 in the epidermis of two Japanese patients with Netherton syndrome.
Konishi T; Tsuda T; Sakaguchi Y; Imai Y; Ito T; Hirota S; Yamanishi K
J Dermatol; 2014 Mar; 41(3):258-61. PubMed ID: 24506793
[TBL] [Abstract][Full Text] [Related]
22. A novel SPINK5 donor splice site variant in a child with Netherton syndrome.
Mintoff D; Borg I; Vornweg J; Mercieca L; Merdzanic R; Numrich J; Aquilina S; Pace NP; Fischer J
Mol Genet Genomic Med; 2021 Mar; 9(3):e1611. PubMed ID: 33534181
[TBL] [Abstract][Full Text] [Related]
23. LEKTI domains D6, D7 and D8+9 serve as substrates for transglutaminase 1: implications for targeted therapy of Netherton syndrome.
Wiegmann H; Valentin F; Tarinski T; Liebau E; Loser K; Traupe H; Oji V
Br J Dermatol; 2019 Nov; 181(5):999-1008. PubMed ID: 30801672
[TBL] [Abstract][Full Text] [Related]
24. A case of Netherton syndrome with mutation in SPINK5 and FLG.
Shi ZR; Xu M; Tan GZ; Wang L; Guo Q; Tang ZQ
Eur J Dermatol; 2017 Oct; 27(5):536-537. PubMed ID: 28943498
[No Abstract] [Full Text] [Related]
25. Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses.
Barbieux C; Bonnet des Claustres M; Fahrner M; Petrova E; Tsoi LC; Gouin O; Leturcq F; Nicaise-Roland P; Bole C; Béziat V; Bourrat E; Schilling O; Gudjonsson JE; Hovnanian A
J Allergy Clin Immunol; 2022 Apr; 149(4):1358-1372. PubMed ID: 34543653
[TBL] [Abstract][Full Text] [Related]
26. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity.
Descargues P; Deraison C; Bonnart C; Kreft M; Kishibe M; Ishida-Yamamoto A; Elias P; Barrandon Y; Zambruno G; Sonnenberg A; Hovnanian A
Nat Genet; 2005 Jan; 37(1):56-65. PubMed ID: 15619623
[TBL] [Abstract][Full Text] [Related]
27. Establishment of an induced pluripotent stem cell line (SAHGMUi001-A) from a patient with Netherton syndrome carrying SPINK5 mutation.
Xu M; Wang L; Yin J; Xiong J; Guo Q; Yang W
Stem Cell Res; 2021 Mar; 51():102213. PubMed ID: 33556917
[TBL] [Abstract][Full Text] [Related]
28. A Novel SPINK5 Gene Mutation Associated with Netherton Syndrome in an Omani Patient.
Hamza N; Al Sukaiti N; Ahmed KAM; Romano R; Gokhale UA; Pan-Hammarström Q
Sultan Qaboos Univ Med J; 2021 Nov; 21(4):652-656. PubMed ID: 34888090
[TBL] [Abstract][Full Text] [Related]
29. A Potent and Selective Kallikrein-5 Inhibitor Delivers High Pharmacological Activity in Skin from Patients with Netherton Syndrome.
Liddle J; Beneton V; Benson M; Bingham R; Bouillot A; Boullay AB; Brook E; Cryan J; Denis A; Edgar E; Ferrie A; Fouchet MH; Grillot D; Holmes DS; Howes A; Krysa G; Laroze A; Lennon M; McClure F; Moquette A; Nicodeme E; Santiago B; Santos L; Smith KJ; Thorpe JH; Thripp G; Trottet L; Walker AL; Ward SA; Wang Y; Wilson S; Pearce AC; Hovnanian A
J Invest Dermatol; 2021 Sep; 141(9):2272-2279. PubMed ID: 33744298
[TBL] [Abstract][Full Text] [Related]
30. Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under Psoriatic Skin Inflammation.
Ogawa T; Ishitsuka Y; Inoue S; Nakamura Y; Saito A; Okiyama N; Fujisawa Y; Furuta J; Watanabe R; Fujimoto M
Am J Pathol; 2020 Mar; 190(3):577-585. PubMed ID: 31953037
[TBL] [Abstract][Full Text] [Related]
31.
Park NJ; Jo BG; Bong SK; Park SA; Lee S; Kim YK; Yang MH; Kim SN
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955819
[TBL] [Abstract][Full Text] [Related]
32. Nrf2 in keratinocytes protects against skin fibrosis via regulating epidermal lesion and inflammatory response.
Wu R; Zhang H; Zhao M; Li J; Hu Y; Fu J; Pi J; Wang H; Xu Y
Biochem Pharmacol; 2020 Apr; 174():113846. PubMed ID: 32032580
[TBL] [Abstract][Full Text] [Related]
33. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.
Roedl D; Oji V; Buters JT; Behrendt H; Braun-Falco M
J Dermatol Sci; 2011 Mar; 61(3):194-8. PubMed ID: 21251800
[TBL] [Abstract][Full Text] [Related]
34. A viable mouse model for Netherton syndrome based on mosaic inactivation of the Spink5 gene.
Kasparek P; Ileninova Z; Haneckova R; Kanchev I; Jenickova I; Sedlacek R
Biol Chem; 2016 Dec; 397(12):1287-1292. PubMed ID: 27543783
[TBL] [Abstract][Full Text] [Related]
35. A compound synonymous mutation c.474G>A with p.Arg578X mutation in SPINK5 causes splicing disorder and mild phenotype in Netherton syndrome.
Numata S; Teye K; Krol RP; Okamatsu Y; Hashikawa K; Matsuda M; Fortugno P; Di Zenzo G; Castiglia D; Zambruno G; Hamada T; Hashimoto T
Exp Dermatol; 2016 Jul; 25(7):568-70. PubMed ID: 26997095
[No Abstract] [Full Text] [Related]
36. Netherton syndrome previously misdiagnosed as hyper IgE syndrome caused by a probable mutation in SPINK5 C.
Özyurt K; Atasoy M; Ertaş R; Ulaş Y; Akkuş MR; Kiraz A; Hennies HC
Turk J Pediatr; 2019; 61(4):604-607. PubMed ID: 31990481
[TBL] [Abstract][Full Text] [Related]
37. Netherton Syndrome in a Mother and Her Two Children.
DeMoss J; Cooper L; Felts C; Wittenberg G
S D Med; 2022 Dec; 75(12):554-556. PubMed ID: 36893349
[TBL] [Abstract][Full Text] [Related]
38. Netherton Syndrome: Insights into Pathogenesis and Clinical Implications.
Chiticariu E; Hohl D
J Invest Dermatol; 2020 Jun; 140(6):1129-1130. PubMed ID: 32446331
[TBL] [Abstract][Full Text] [Related]
39. Netherton Syndrome: A Genotype-Phenotype Review.
Sarri CA; Roussaki-Schulze A; Vasilopoulos Y; Zafiriou E; Patsatsi A; Stamatis C; Gidarokosta P; Sotiriadis D; Sarafidou T; Mamuris Z
Mol Diagn Ther; 2017 Apr; 21(2):137-152. PubMed ID: 27905021
[TBL] [Abstract][Full Text] [Related]
40. Netherton syndrome caused by compound heterozygous mutation, c.80A>G mutation in SPINK5 and large-sized genomic deletion mutation, and successful treatment of intravenous immunoglobulin.
Zhang Z; Pan C; Wei R; Li H; Yang Y; Chen J; Li M; Yao Z
Mol Genet Genomic Med; 2021 Mar; 9(3):e1600. PubMed ID: 33452875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
